Clinical Trials: Page 4
-
Stock via Getty Images
AFib study shows no effect on outcomes from 1-year delay of catheter ablation
Early treatment could be a boon for medtech companies such as Boston Scientific and Medtronic but is potentially challenging for healthcare systems. The new study suggests waits of up to a year will not harm patients.
By Nick Paul Taylor • April 19, 2023 -
Courtesy of Walgreens
OTC hearing aid matches performance of audiologist-fitted device in small trial
People who used an over-the-counter hearing aid for six weeks saw similar results to people who used an audiologist-fitted device, suggesting less costly, self-fitted hearing aids could be an option.
By Nick Paul Taylor • April 13, 2023 -
Permission granted by Abbott
Implantable heart failure sensors cut death risk in study: Abbott
Philip Adamson, chief medical officer for Abbott’s heart failure business, called the finding “profound.”
By Susan Kelly • March 27, 2023 -
Courtesy of Tandem Diabetes
Tandem, targeting Medtronic and Insulet’s turf, links artificial pancreas to improved outcomes in kids
If Tandem can prove to regulators that the system can help manage young children’s diabetes, it could compete with Medtronic and Insulet, which have devices that are indicated for use in kids as young as two years.
By Nick Paul Taylor • March 16, 2023 -
Courtesy of Medtronic
Medtronic’s pulsed field ablation device meets safety, efficacy metrics in trial
Medtronic’s device didn’t outperform competing systems being developed by J&J and Boston Scientific, but the results should be enough to secure FDA approval, one analyst wrote.
By Elise Reuter • March 7, 2023 -
Permission granted by Medtronic
Medtronic TAVR data in healthier patients fuels battle with Edwards for heart valve market share
The results show that low-risk aortic stenosis patients have better outcomes after three years when catheters are used to insert their replacement heart valves, rather than traditional open-heart surgery.
By Nick Paul Taylor • March 7, 2023 -
Courtesy of Abbott
Abbott’s TriClip improves tricuspid regurgitation in pivotal trial ahead of showdown with Edwards
The transcatheter repair clip beat the established medical therapy on the primary composite endpoint, setting up a battle with rival Edwards for a $5 billion market.
By Nick Paul Taylor • March 6, 2023 -
Paula Bronstein via Getty Images
Phone app tracks cough frequency in tuberculosis trial, opening up monitoring opportunity
If validated in further studies, the work could further expand the use of smartphones as diagnostic tools, particularly in areas where there are few medical professionals, and could help stop overtreatment of TB.
By Nick Paul Taylor • March 6, 2023 -
Win McNamee / staff via Getty Images
Elon Musk’s bid to study brain implant in humans rejected by FDA on safety grounds: report
The FDA reportedly raised concerns about the device’s lithium battery, the potential for its wires to migrate across the brain, and how it would be removed.
By Nick Paul Taylor • March 3, 2023 -
Courtesy of Recor
ReCor follows Medtronic in making case for renal denervation as FDA mulls approval decision
An analysis of three clinical trials linked the intervention to consistent reductions in blood pressure.
By Nick Paul Taylor • March 1, 2023 -
Courtesy of Medtronic
Medtronic links MiniMed 780G automated insulin delivery to sustained glucose control benefits
The data indicates patients should receive automated insulin delivery earlier, rather than starting treatment with multiple daily injections, Medtronic said.
By Nick Paul Taylor • Feb. 27, 2023 -
libre de droit via Getty Images
Spinal cord stimulation shows ability to improve motor function in stroke patients in small trial
The spinal implant improved strength, grip force and movement, enabling participants to recover the use of limbs incapacitated by stroke.
By Nick Paul Taylor • Feb. 21, 2023 -
Courtesy of Johnson & Johnson
J&J, Medtronic, Boston Scientific gird for battle over US cardiac ablation market with new trials
Medtech firms are sharing clinical trial results on pulse ablation devices, which they claim are safer and more effective at halting arrhythmias than current methods.
By Elise Reuter • Feb. 8, 2023 -
Adam Berry via Getty Images
CT scans offer new path to diagnose treatable cause of high blood pressure, study shows
While the approach could increase demand for CT imaging, the supply of radioactive tracers is potentially a barrier to adoption of the technique.
By Nick Paul Taylor • Jan. 19, 2023 -
yodiyim via Getty Images
AI predicts lung cancer risk six years into the future using single CT scan: study
A research team has made the deep learning model publicly available and says it has no intention to commercialize it.
By Nick Paul Taylor • Jan. 17, 2023 -
Courtesy of LabCorp
Labcorp hires ex-Quintiles CEO to lead clinical development unit ahead of upcoming spinoff
Thomas Pike, who oversaw the transformational merger of Quintiles and IMS Health, will be in charge of a CRO for the first time since 2016.
By Nick Paul Taylor • Jan. 6, 2023 -
Lisa Maree Williams via Getty Images
AstraZeneca extends C2i pact to validate minimal residual disease solid tumor blood test
The technology could improve cancer treatment and support clinical trial recruitment and monitoring.
By Nick Paul Taylor • Jan. 6, 2023 -
SciePro via Getty Images
Novocure shares jump on positive lung cancer data
A regimen involving the Swiss biotech’s electrical field-based treatment extended lives in a late-stage trial. But data comparing the medical device to standard chemotherapy is less persuasive.
By Jonathan Gardner • Jan. 5, 2023 -
Permission granted by Freenome
Q&AFreenome CEO Mike Nolan talks colorectal cancer test, clinical trials
The San Francisco-based company recently enrolled a clinical trial for its blood-based cancer test but faces competition in the market for minimally invasive cancer tests.
By Elise Reuter • Dec. 22, 2022 -
Courtesy of Medtronic
Medtronic starts US robotic surgery trial in push to challenge Intuitive
Medtronic delayed the Hugo program to make changes in light of surgeon feedback, but now plans to evaluate the use of the surgical robot in urologic procedures, facing off against competitor Intuitive.
By Nick Paul Taylor • Dec. 20, 2022 -
titoOnz via Getty Images
MDR costs are driving manufacturers to pull products from European market: report
The report adds to evidence that makers of products used for pediatric patients and rare diseases have been particularly hard hit.
By Nick Paul Taylor • Dec. 20, 2022 -
Guardant Health
Pivotal data on Guardant’s colorectal cancer blood test raise doubts about commercial prospects
Guardant’s share price fell 27% after the release of the news, which raised questions about whether the test can drive sales growth.
By Nick Paul Taylor • Dec. 19, 2022 -
Courtesy of Synchron
Gates, Bezos invest in Synchron’s brain computer interface
A $75 million investment will accelerate the development of a drill-free implant to help patients with upper-limb paralysis.
By Peter Green • Dec. 16, 2022 -
Courtesy of Vaxxas
Investors hand Vaxxas $23M to support trial of needle-free COVID-19 vaccine
With support from the Gates Foundation, the needle-free technology could get more people vaccinated and avoid cold-chain issues.
By Nick Paul Taylor • Dec. 12, 2022 -
Johnny Greig via Getty Images
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022
Previous
